Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia in women may be improved by targeting oxidative stress, inflammation, and fibrosis.

Frontal fibrosing alopecia can mimic traction alopecia but has distinct features like facial papules and eyebrow thinning.

HDAC6 helps keep ovarian follicles dormant, extending female fertility.

Quarantine stress likely worsened hair loss in women, but video consultations helped manage their condition and reduce anxiety.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Recognizing myxedema coma is crucial due to its high risk and unusual symptoms.

Pandemic stress worsens hair loss and skin issues, suggesting combined mental and skin care treatments.

Telogen effluvium is linked to deficiencies in iron, vitamin B12, and thyroid function.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

An integrated approach with accurate diagnosis and targeted treatment improves outcomes for female hair loss.

Many Korean women with female-pattern hair loss have reduced hair density at the temples.

Early biopsy and targeting inflammation can improve treatment for hair loss in androgenetic alopecia.

Telogen effluvium is a condition that causes temporary hair loss due to stress or shock to the body.

Lipid peroxides can cause early hair loss by damaging hair follicles.

Postpartum hair loss is common, temporary, and linked to hormonal changes, stress, and nutrition.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

Radiation-induced hair loss may be caused by hair growth stopping and inflammation in blood vessels.

High levels of fatty acids are linked to increased androgen production and inflammation in women with PCOS, which may affect IVF outcomes.

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

Ovarian tumors should be considered when postmenopausal women show signs of virilization.

Reassurance and counseling are key in managing acute telogen effluvium, with supplements possibly offering a placebo effect.

Frontal fibrosing alopecia in Bogotá mainly affects postmenopausal women, with possible links to hormonal changes and sunscreen use.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Taxane chemotherapy can cause permanent hair loss by damaging hair follicles and altering their DNA.

HIF-1α is important for hair growth and could be a treatment target for hair loss.

Oxidative stress may play a role in causing androgenetic alopecia.

Leydig cell tumors in the ovary can cause high testosterone and male traits in postmenopausal women but are treatable with surgery.

Female pattern alopecia causes hair thinning due to shrinking hair follicles.

A postmenopausal woman had rare symptoms due to a possible ovarian tumor, needing thorough evaluation.